BRIEFLY

Stockwatch Daily - - HEALTH CARE -

- Ap­tose Bio­sciences Inc. spent $1.74-mil­lion on re­search and devel­op­ment in Q3 2017. The com­pany spent $2.16-mil­lion on re­search and devel­op­ment in Q3 2016. The com­pany lost $3.3-mil­lion in Q3 2017. (APS) $2.50

- Aurinia Phar­ma­ceu­ti­cals Inc. loses $13.2-mil­lion (U.S.) on rev­enue of $29,000 (U.S.). The com­pany lost $7.41-mil­lion (U.S.) on rev­enue of $31,000 (U.S.) dur­ing the same pe­riod last year. (AUP) $6.77

- Breathtec Biomed­i­cal Inc. has been halted at 6:41 a.m. PT on Nov. 14, 2017, pend­ing com­pany con­tact. (BTH) $0.13

- Breathtec Biomed­i­cal Inc. will re­sume at 12 p.m. PT on Nov. 14, 2017. (BTH) $0.13

- Car­diome Pharma Corp. lost $6.62-mil­lion (U.S.) on rev­enue of $6.02-mil­lion (U.S.) in the third quar­ter of 2017. It lost $5.28-mil­lion (U.S.) on rev­enue of $5.23-mil­lion (U.S.) in the same pe­riod last year. (COM) $1.83

- Con­cor­dia In­ter­na­tional Corp. lost $69.48-mil­lion (U.S.) on rev­enue of $154.62-mil­lion (U.S.) in the third quar­ter of 2017. This com­pares with a loss of $75.14-mil­lion (U.S.) on rev­enue of $185.5-mil­lion (U.S.) in Q3 of 2016. (CXR) $0.68

- Co­valon Tech­nolo­gies Ltd. has ap­pointed re­tired Ma­jor-Gen­eral Gale Pol­lock to its board of di­rec­tors. Gen. Pol­lock was the Act­ing Sur­geon Gen­eral of the U.S. Army. (COV) $4.95

- GLG Life Tech Corp. lost $5.29-mil­lion on rev­enues of $4.15-mil­lion in the third quar­ter ended Sept. 30, 2017. The com­pany lost $5.85-mil­lion on rev­enues of $8.8-mil­lion in the same pe­riod last year. (GLG) $1.13

- Kane Biotech lost $869,246 on rev­enue of $60,727 in the third quar­ter ended Sept. 30, 2017. This com­pares with a loss of $616,063 on rev­enue of $59,278 in the same quar­ter a year ear­lier. (KNE) $0.15

- Neo­vasc Inc. lost $4.69-mil­lion (U.S.) on rev­enue of $1.37-mil­lion (U.S.) in the third quar­ter of 2017. This com­pares with a loss of $29.13-mil­lion (U.S.) on rev­enue of $3.03-mil­lion (U.S.) in the same pe­riod last year. (NVCN) $1.05

- Quest Phar­mat­ech Inc. sub­sidiary On­coQuest will present pre­clin­i­cal data on its im­munother­apy tech­nol­ogy at the an­nual SITC meet­ing. (QPT) $0.11

- Si­enna Se­nior Liv­ing Inc. had a $6.21-mil­lion con­tin­u­ing op­er­a­tions profit on rev­enue of $139.86-mil­lion in the third quar­ter ended Sept. 30, 2017. It had a $364,000 con­tin­u­ing op­er­a­tions loss on rev­enue of $130.41-mil­lion in the same quar­ter a year ago. (SIA) $18.20

- Spec­tral Med­i­cal Inc. lost $820,000 on rev­enues of $857,000 in the third quar­ter ended Sept. 30, 2017. The com­pany lost $2.65-mil­lion on rev­enues of $807,000 in the same pe­riod a year ear­lier. (EDT) $0.37

- Ti­tan Med­i­cal Inc. has filed a pre­lim­i­nary short-form prospec­tus for a unit of­fer­ing. Each unit will con­sist of one share and one-half war­rant. The com­pany will de­ter­mine the of­fer­ing size and war­rant terms at the time of pric­ing. (TMD) $0.58

- Valeant Phar­ma­ceu­ti­cals In­ter­na­tional Inc. has set the price for its $750-mil­lion ag­gre­gate prin­ci­pal amount 5.5 per cent se­nior se­cured notes due 2025. The notes will be sold at 100 per cent of the prin­ci­pal amount plus ac­crued in­ter­est from Oct. 17, 2017. (VRX) $18.19

- Vigil Health So­lu­tions Inc. earned $10,073 on rev­enue of $1.61-mil­lion in the sec­ond quar­ter ended Sept. 30, 2017. It earned $112,685 on rev­enue of $1.57-mil­lion in the same pe­riod last year. (VGL) $0.66

Newspapers in English

Newspapers from Canada

© PressReader. All rights reserved.